|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Gilead Sciences |
|---|---|
| Collaborator: |
Anderson Clinical Research |
| Information provided by: | NIH AIDS Clinical Trials Information Service |
| ClinicalTrials.gov Identifier: | NCT00002384 |
Purpose
Incomplete Closed Protocol
| Condition | Intervention |
|---|---|
|
Cytomegalovirus Retinitis HIV Infections |
Drug: Cidofovir |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Vistide (Cidofovir Intravenous) Treatment IND Protocol for Relapsing Cytomegalovirus Retinitis in Patients With AIDS |
Eligibility| Ages Eligible for Study: | 13 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Information not available
Contacts and Locations
More Information
| Study ID Numbers: | 276A, GS-95-120, 96ACR-GIL1 |
| Study First Received: | November 2, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00002384 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
Anti-Infective Agents Sexually Transmitted Diseases, Viral Slow Virus Diseases Antineoplastic Agents Physiological Effects of Drugs Retinitis Infection Anti-Retroviral Agents Therapeutic Uses Cytomegalovirus Infections Retroviridae Infections Retinal Diseases Cidofovir RNA Virus Infections Anti-HIV Agents |
Immune System Diseases Eye Infections, Viral Eye Diseases Cytomegalovirus Retinitis Acquired Immunodeficiency Syndrome Eye Infections Antiviral Agents Immunologic Deficiency Syndromes Pharmacologic Actions Herpesviridae Infections Virus Diseases Radiation-Sensitizing Agents HIV Infections Sexually Transmitted Diseases Lentivirus Infections |